There is other options for financing through the different phases without dilutive Cap raises.
Big Pharma partnering and or cornerstone investment is likely on FDA approval IMO.
Some dilution is likely going forward but to use an extra 1.3billion shares in your calculations is flawed logic IMO.
There is other options for financing through the different...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
-0.005(9.09%) |
Mkt cap ! $7.23M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.3¢ | 4.8¢ | $11.88K | 243.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 12068 | 1 |
View Market Depth
| Last trade - 13.00pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.3¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.3¢ | 5.3¢ | 257 | ||
| Last updated 10.57am 06/05/2024 ? | |||||
| NSB (ASX) Chart |